PROCYON CORP
10QSB, EX-27, 2000-11-07
PHARMACEUTICAL PREPARATIONS
Previous: PROCYON CORP, 10QSB, 2000-11-07
Next: DEL TACO INCOME PROPERTIES IV, 10-Q, 2000-11-07



<TABLE> <S> <C>


<ARTICLE> 5
<MULTIPLIER> 1

<S>                                        <C>
<PERIOD-TYPE>                                    3-MOS
<FISCAL-YEAR-END>                          JUN-30-2001
<PERIOD-END>                               SEP-30-2000
<CASH>                                         326,697
<SECURITIES>                                         0
<RECEIVABLES>                                    5,815
<ALLOWANCES>                                       500
<INVENTORY>                                     60,821
<CURRENT-ASSETS>                               440,015
<PP&E>                                          35,614
<DEPRECIATION>                                  28,439
<TOTAL-ASSETS>                                 483,905
<CURRENT-LIABILITIES>                           86,495
<BONDS>                                              0
                                0
                                    292,783
<COMMON>                                     4,214,081
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   483,905
<SALES>                                        203,349
<TOTAL-REVENUES>                               208,395
<CGS>                                           35,499
<TOTAL-COSTS>                                  276,127
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 285
<INCOME-PRETAX>                               (103,516)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (103,516)
<EPS-BASIC>                                      (0.03)
<EPS-DILUTED>                                    (0.03)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission